Capitol Clarity / Firms / Todd Strategy Group

Todd Strategy Group

Todd Strategy Group is a registered federal lobbying firm. For Q3 2026 it reported $3.56M across 64 client reports and lists 11 lobbyists across its filings. Issues include Health Issues, Medicare/Medicaid, Pharmacy and Trade (domestic/foreign).

Clients, Q3 2026

ClientReportedIssues
MEDICAL COUNTERMEASURES COALITION$130KHealth Issues
JOHNSON & JOHNSON SERVICES, INC.$100KHealth Issues, Veterans
THE COALITION FOR 21ST CENTURY MEDICINE$90KMedicare/Medicaid
GILEAD SCIENCES, INC.$80KHealth Issues
ELI LILLY AND COMPANY$80KHealth Issues, Medicare/Medicaid, Pharmacy
BRISTOL-MYERS SQUIBB COMPANY$80KHealth Issues, Medicare/Medicaid, Pharmacy
COMPASS PATHWAYS INC.$80KHealth Issues
AMGEN INC.$80KBudget/Appropriations, Copyright/Patent/Trademark, Health Issues
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA$80KBudget/Appropriations, Copyright/Patent/Trademark, Health Issues
ASTRAZENECA PHARMACEUTICALS LP$80KHealth Issues, Medicare/Medicaid, Pharmacy
ACTION NOW INITIATIVE, LLC$70KEducation, Labor Issues/Antitrust/Workplace
PMI US CORPORATE SERVICES INC.$60KBudget/Appropriations, Government Issues, Tobacco
APOLLO GLOBAL MANAGEMENT$60KFinancial Institutions/Investments/Securities
GENMAB$60KHealth Issues, Medicare/Medicaid
AMERICAN MEDICAL ASSOCIATION$60KHealth Issues, Medicare/Medicaid, Pharmacy
PFIZER INC.$60KMedicare/Medicaid, Pharmacy
NOVO NORDISK INC.$60KHealth Issues, Pharmacy
VANTIVE US HEALTHCARE LLC$60KHealth Issues
GLAXOSMITHKLINE LLC$60KHealth Issues, Medicare/Medicaid
VAXART INC.$60KMedical/Disease Research/Clinical Labs
INSULET CORPORATION$60KHealth Issues
DELFI DIAGNOSTICS$60KHealth Issues, Pharmacy, Trade (domestic/foreign)
INOVIO PHARMACEUTICALS$60KHealth Issues
ALNYLAM PHARMACEUTICALS, INC.$60KMedicare/Medicaid, Pharmacy, Trade (domestic/foreign)
GENENTECH, INC.$60KBudget/Appropriations, Copyright/Patent/Trademark, Health Issues
ALKERMES, INC.$60KHealth Issues, Medicare/Medicaid
NOVARTIS, INC.$60KHealth Issues, Medicare/Medicaid, Trade (domestic/foreign)
PUERTO RICO DEPARTMENT OF HEALTH$50KBudget/Appropriations, Medicare/Medicaid
OTSUKA AMERICA PHARMACEUTICAL, INC.$50KHealth Issues
TAKEDA PHARMACEUTICALS AMERICA, INC.$50KHealth Issues, Medicare/Medicaid, Trade (domestic/foreign)
FOX CORPORATION$50KCommunications/Broadcasting/Radio/TV
EXELIXIS, INC.$50KCopyright/Patent/Trademark, Health Issues, Medicare/Medicaid
ILLUMINA, INC.$50KHealth Issues, Medicare/Medicaid, Trade (domestic/foreign)
PERIMETER SYSTEMS, INC.$50KHealth Issues
NOMI HEALTH, INC.$50KHealth Issues
MUTUAL OF OMAHA$50KInsurance
ASTELLAS PHARMA US, INC.$50KCopyright/Patent/Trademark, Health Issues, Medicare/Medicaid
U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER$50KCopyright/Patent/Trademark
NATIONAL EDUCATION ASSOCIATION$50KEducation
NCTA - THE INTERNET & TELEVISION ASSOCIATION$50KTelecommunications
MILLIPORESIGMA$50KPharmacy
CALYXO, INC.$50KHealth Issues
SUNBOUND HOMES$50KMedicare/Medicaid
MRO CORPORATION$50KHealth Issues
FREENOME$50KHealth Issues, Medicare/Medicaid
PERSONALIS, INC.$50KMedicare/Medicaid, Pharmacy
MCKESSON CORPORATION$50KMedicare/Medicaid
EMD SERONO INC.$50KHealth Issues, Trade (domestic/foreign)
BAYER CORPORATION$50KCopyright/Patent/Trademark, Health Issues, Medicare/Medicaid
BIOGEN, INC.$50KHealth Issues, Pharmacy
MERCK & CO., INC.$50KHealth Issues, Medicare/Medicaid
SIDECAR HEALTH$50KHealth Issues
AMERICAN SOCIETY OF NEPHROLOGY$40KHealth Issues
VALISURE$40KPharmacy
INFLAMMATIX, INC.$40KMedicare/Medicaid
AMERICAN COLLEGE OF RADIOLOGY$40KMedicare/Medicaid
MYRIAD GENETICS, INC.$40KMedicare/Medicaid
SOUTHWEST TRANSPLANT ALLIANCE$30KHealth Issues
CALIFORNIA SCHOOL BOARDS ASSOCIATION$30KEducation
DC CHARTER SCHOOLS ACTION$30KBudget/Appropriations
MENARINI GROUP$30KMedicare/Medicaid
HEALTHCARE PRIVACY FORUM, LLC D/B/A HEALTHCARE TRUST INSTITUTE$30KHealth Issues
BIODESIX, INC.$30KHealth Issues, Medicare/Medicaid
COAST PROFESSIONAL, INC.$20KBudget/Appropriations

By year

YearReportedClients
2026$10.78M75
2025$14.46M80

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.